Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Rachael E. Redgrave"'
Autor:
Maria Camacho-Encina, Laura K. Booth, Rachael E. Redgrave, Omowumi Folaranmi, Ioakim Spyridopoulos, Gavin D. Richardson
Publikováno v:
Cells, Vol 13, Iss 4, p 353 (2024)
Cardiovascular diseases (CVDs), a group of disorders affecting the heart or blood vessels, are the primary cause of death worldwide, with an immense impact on patient quality of life and disability. According to the World Health Organization, CVD tak
Externí odkaz:
https://doaj.org/article/9f2738edc5dc4a2094a9568a90c44cec
Publikováno v:
Frontiers in Aging, Vol 3 (2022)
Cancer continues to place a heavy burden on healthcare systems around the world. Although cancer survivorship continues to improve, cardiotoxicity leading to cardiomyopathy and heart failure as a consequence of cancer therapy is rising, and yesterday
Externí odkaz:
https://doaj.org/article/6dec66949d2e44a1be92fcf8d44d1f9f
Autor:
Nina P. Jordan, Samuel J. Tingle, Victoria G. Shuttleworth, Katie Cooke, Rachael E. Redgrave, Esha Singh, Emily K. Glover, Hafiza B. Ahmad Tajuddin, John A. Kirby, Helen M. Arthur, Chris Ward, Neil S. Sheerin, Simi Ali
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 16, p 8629 (2021)
In fibrotic diseases, myofibroblasts derive from a range of cell types including endothelial-to-mesenchymal transition (EndMT). Increasing evidence suggests that miRNAs are key regulators in biological processes but their profile is relatively unders
Externí odkaz:
https://doaj.org/article/a8e96d517b374b079a772b097d79f626
Autor:
Rachael E. Redgrave, Simon Tual-Chalot, Benjamin J. Davison, Esha Singh, Darroch Hall, Muhammad M. Amirrasouli, Derek Gilchrist, Alexander Medvinsky, Helen M. Arthur
Publikováno v:
Stem Cell Reports, Vol 8, Iss 5, Pp 1287-1298 (2017)
Clinical trials of stem cell therapy to treat ischemic heart disease primarily use heterogeneous stem cell populations. Small benefits occur via paracrine mechanisms that include stimulating angiogenesis, and increased understanding of these mechanis
Externí odkaz:
https://doaj.org/article/d5f5bb31bf8c4143b42eecd15fa139de
Autor:
Rachael E. Redgrave, Simon Tual-Chalot, Benjamin J. Davison, Elizabeth Greally, Mauro Santibanez-Koref, Jurgen E. Schneider, Andrew M. Blamire, Helen M. Arthur
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 11, Iss C, Pp 29-34 (2016)
Background: Mice are frequently used in research to examine outcomes of myocardial infarction (MI) and to investigate therapeutic interventions at an early pre-clinical stage. The MI model is generated by surgically occluding a major coronary artery,
Externí odkaz:
https://doaj.org/article/f3a4dcba75044e52891034366c23532c
Autor:
Rachael E. Redgrave, Esha Singh, Simon Tual-Chalot, Catherine Park, Darroch Hall, Karim Bennaceur, Danielle J. Smyth, Rick M. Maizels, Ioakim Spyridopoulos, Helen M. Arthur
RationaleSuccessful and timely coronary reperfusion following acute ST-elevation myocardial infarction (STEMI) is standard therapy to salvage transiently ischaemic heart muscle. However, the subsequent inflammatory response within the infarct can lea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44bccdf3befd37fa3c86f1a8e6717976
https://doi.org/10.1101/2023.04.18.537417
https://doi.org/10.1101/2023.04.18.537417
Autor:
Laura K. Booth, Rachael E. Redgrave, Simon Tual-Chalot, Ioakim Spyridopoulos, Helen M. Phillips, Gavin D. Richardson
Publikováno v:
Subcellular Biochemistry ISBN: 9783031265754
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44608132f5f83b8dfbcd85ab0bd2b219
https://doi.org/10.1007/978-3-031-26576-1_4
https://doi.org/10.1007/978-3-031-26576-1_4
Autor:
Rachael E, Redgrave, Simon, Tual-Chalot, Benjamin J, Davison, Elizabeth, Greally, Mauro, Santibanez-Koref, Jurgen E, Schneider, Andrew M, Blamire, Helen M, Arthur
Publikováno v:
International Journal of Cardiology. Heart & Vasculature
Background Mice are frequently used in research to examine outcomes of myocardial infarction (MI) and to investigate therapeutic interventions at an early pre-clinical stage. The MI model is generated by surgically occluding a major coronary artery,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::545c9007ada8c4ec2c45aab8fde575ba
https://pubmed.ncbi.nlm.nih.gov/27882341
https://pubmed.ncbi.nlm.nih.gov/27882341
Autor:
Simon Tual-Chalot, Marwa Mahmoud, Kathleen R Allinson, Rachael E Redgrave, Zhenhua Zhai, S Paul Oh, Marcus Fruttiger, Helen M Arthur
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98646 (2014)
Rare inherited cardiovascular diseases are frequently caused by mutations in genes that are essential for the formation and/or function of the cardiovasculature. Hereditary Haemorrhagic Telangiectasia is a familial disease of this type. The majority
Externí odkaz:
https://doaj.org/article/5d52fe5818944569bdd0265c10f358a5